Vilin Bio Med

Vilin Bio Med

26.25
+1.25
(5.00%)
Market Cap
36.62 Cr
EPS
0.16
PE Ratio
156.25
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
32.50
52 Week Low
15.40
PB Ratio
1.51
Debt to Equity
0.35
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,733.80
#1 4,15,996.70
35.83
#1 54,729.00
12.06
#1 10,980
-18.99
64.93
6,650.00
1,76,536.61
80.94
9,712.00
0.89
2,191
23.05
46.65
3,730.60
1,26,260.46
63.15
11,539.40
6.99
1,911
19.91
74.11
1,559.40
1,25,953.96
23.58
28,409.50
7.12
5,291
9.88
65.36
1,292.10
1,07,834.93
#1 19.10
33,741.20
16.73
5,725
1.26
55.19
2,575.50
1,06,298.29
60.68
12,744.20
19.57
2,007
-10.91
55.92
995.15
1,00,135.38
21.54
23,511.00
13.82
4,615
-0.19
61.25
1,984.60
90,635.78
27.91
22,909.50
#1 19.94
3,306
#1 112.49
58.19
35,195.00
74,786.92
52.17
6,684.70
10.80
1,414
27.83
60.78
1,158.00
67,256.83
19.47
31,378.10
17.55
3,366
-0.50
55.87
Forecast
Actual
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-219.28 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
TTM
Revenue
17
12
11
12
16
15
8
Expenses
16
11
10
10
15
14
7
EBITDA
1
1
1
3
1
1
2
Operating Profit %
5 %
7 %
7 %
21 %
5 %
5 %
8 %
Depreciation
0
0
0
0
0
0
0
Interest
0
0
1
1
1
1
0
Profit Before Tax
0
0
0
2
0
0
1
Tax
0
0
0
1
0
0
0
Net Profit
0
0
0
1
0
0
1
EPS in ₹
0.20
0.15
0.10
1.25
0.12
0.16
2.20

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
14
14
14
18
32
28
Fixed Assets
2
2
2
2
1
3
Current Assets
12
12
12
8
19
13
Capital Work in Progress
0
0
0
0
0
2
Investments
0
0
0
0
0
4
Other Assets
12
12
12
16
31
0
Total Liabilities
14
14
14
18
32
28
Current Liabilities
7
6
5
7
9
5
Non Current Liabilities
0
1
1
1
0
0
Total Equity
7
7
7
11
23
23
Reserve & Surplus
4
4
4
1
9
9
Share Capital
3
3
3
10
14
14

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
0
6
Investing Activities
0
0
0
0
0
Operating Activities
-2
-1
0
-2
-5
Financing Activities
2
1
-0
2
11

Share Holding

% Holding
Jun 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Jun 2025
Promoter
90.45 %
64.52 %
64.52 %
64.09 %
63.89 %
63.89 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
9.45 %
32.80 %
33.84 %
34.47 %
34.18 %
33.49 %
Others
0.10 %
2.68 %
1.65 %
1.45 %
1.94 %
2.62 %
No of Share Holders
827
659
585
581
551
492

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
17 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
17 May 2025 25.35 26.55
30 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Oct 2024 24.40 22.90
21 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
21 Sept 2024 18.85 18.05

Technical Indicators

RSI(14)
Neutral
36.43
ATR(14)
Less Volatile
0.47
STOCH(9,6)
Oversold
6.14
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-0.11
ADX(14)
Weak Trend
15.49
UO(9)
Bullish
7.87
ROC(12)
Downtrend But Slowing Down
-2.91
WillR(14)
Oversold
-100.00